Navigation Links
ePharmaSolutions Launches an Innovative Patient Recruitment Application for Windows 8

CONSHOHOCKEN, Pa., Nov. 15, 2012 /PRNewswire/ -- ePharmaSolutions announces the launch of PatientLive™, an innovative new patient recruitment application for the new Windows 8 platform.

ePharmaSolutions, a leading clinical services and technology solutions provider has developed a suite of applications that will help change the way patients are recruited and triaged into clinical studies.  The solution includes a consumer and sponsor component that will provide pharmaceutical companies and CROs with a better return on their recruitment investment while providing patients with more information about clinical trials and improved chances to enroll into studies for which they may qualify. 

"This is really a game changing application for the pharmaceutical companies and the patients who are interested in participating in research studies," stated Lance Converse, ePharmaSolutions' Founder and CEO.   "We are providing sponsors with ways to optimize their recruitment spend while offering patients personalized, geo-targeted information about new medical therapies and clinical trial opportunities using unique matching algorithms."

"ePharmaSolutions has been working closely with Microsoft on the development of several clinical trial applications using SharePoint 2010, Azure and Windows 8," stated Chad Brooks, Healthcare Partner Architect Evangelist for Windows 8 at Microsoft.   "When they came to us with this new idea for improving the patient recruitment process we got involved immediately to offer it as part of the new Windows 8 platform."

The PatientLive™ app will be an integrated component of a groundbreaking initiative that ePharmaSolutions is spearheading to bring together more than a dozen major pharmaceutical companies and CROs to "share" potential study participants who disqualify for each other's studies – aptly named "Patient Sharing."   The Patient Sharing initiative will leverage the recruitment spend from each of the participating sponsors by immediately presenting people who are deemed ineligible for one study with other pertinent study opportunities based on previous screening responses.  Seeing as approximately 90% of people will not qualify for the first study they express interest in, the benefit for pharmaceutical companies to participate in the consortium is clear.

About ePharmaSolutions

ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.   ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 300,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit or email   Contact Lance Converse, CEO.

SOURCE ePharmaSolutions
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Coloplast Launches the Innovative Altis Single Incision Sling System
2. CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use
3. AdvaMed Launches MVP Mentoring Portal for Veterans
4. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
5. AASLD Curriculum & Training (ACT) Launches With New Interactive HCV Education
6. Sarnova Launches Curaplex Private Label Brand
7. Zimmer Launches Smartphone Comeback App Globally
8. OKI Europe Launches Cost-effective DICOM-embedded LED Printer Range - a First for Medical Imaging and Printing
9. Amdocs Launches Cloud-Based eHealth Solutions to Give Service Providers Fast Entry to Growing Market
10. Eaton Scientific Expands Investor Relations Strategy and Launches Important New Website Content
11. Georgia Prescription Drug Abuse Prevention Initiative Launches Awareness Campaign
Post Your Comments:
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/26/2015)... ON and Cambridge, ON (PRWEB) , ... November ... ... today the availability of a real-time eReferral system for diagnostic imaging in the ... ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic medical ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... opinion process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits ... place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a global ... attracts volunteers together who want to combine talents and resources to help create ... the process. The non-profit launched its first major fundraiser on November 6, 2015 ...
(Date:11/25/2015)... ... 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever clinic ... the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 ... need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... encouraging people across the country to celebrate their sobriety and show through pictures ... post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their ...
Breaking Medicine News(10 mins):